Reliability By Design Custom Assemblies, Integrated Supply, And Regulatory Readiness In Single-Use Bioprocessing

By Galen Dao, SaniSure

As biopharmaceutical manufacturing becomes more complex, reliability is no longer measured solely by product performance. It is defined by the ability of single-use systems to support consistent operations, maintain supply continuity, and satisfy evolving regulatory expectations. Manufacturers developing biologics, cell and gene therapies, mRNA products, and viral vectors face increasing pressure to reduce contamination risk, accelerate scale-up, and ensure uninterrupted production in an increasingly regulated environment.

A growing focus on reliability by design is reshaping how single-use assemblies are developed and deployed. By combining process-specific custom assembly design with validated component libraries, manufacturers can create tailored fluid paths while preserving consistency, traceability, and scalability. At the same time, vertically integrated manufacturing models help reduce supply chain variability, simplify documentation, and improve delivery predictability. Regulatory developments, including EU GMP Annex 1, PUPSIT requirements, and the USP <665>/<1665> framework, further reinforce the need for systems that are engineered with compliance and risk mitigation in mind from the outset.

Discover how integrating design, supply strategy, validation, and regulatory readiness can help build more resilient and scalable bioprocessing operations.